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ABSTRACT
Homologous recombination (HR) is a highly accur-
ate mechanism of DNA repair that can be exploited
for homology-directed gene targeting. Since in most
cell types HR occurs very infrequently (~10
 6 to
10
 8), its practical application has been largely
restricted to specific experimental systems that
allow selection of the few cells that become genet-
ically modified. HR-mediated gene targeting has
nonetheless revolutionized genetics by greatly
facilitating the analysis of mammalian gene
function. Recent studies showed that generation of
double-strand DNA breaks at specific loci by
designed endonucleases greatly increases the rate
of homology-directed gene repair. These findings
opened new perspectives for HR-based genome
editing in higher eukaryotes. Here, we demonstrate
by using donor DNA templates together with the
adeno-associated virus (AAV) Rep78 and Rep68
proteins that sequence- and strand-specific cleav-
age at a native, predefined, human locus can also
greatly enhance homology-directed gene targeting.
Our findings argue for the development of other
strategies besides direct induction of double-
strand chromosomal breaks to achieve efficient
and heritable targeted genetic modification of cells
and organisms. Finally, harnessing the cellular HR
pathway through Rep-mediated nicking expands
the range of strategies that make use of AAV
elements to bring about stable genetic modification
of human cells.
INTRODUCTION
Homologous recombination (HR) ensures the high-ﬁdelity
repair of genomes by using homologous DNA sequences
(e.g. sister chromatids) as templates for correction (1).
Under normal conditions, HR is a rare event in most
mammalian cell types. In HeLa and HT-1080 cells it
occurs at frequencies of  10
 7 to 10
 8 (2,3) and 10
 6 to
10
 7 (3–5), respectively, whereas in human ﬁbroblasts it
has an incidence of  10
 7 (6). Due to these low HR rates,
homology-directed genome editing techniques have heav-
ily depended on the use of stringent cell selection
procedures that are not easily applicable beyond purely
experimental systems. Even so, the exploitation of HR-
mediated gene targeting has greatly impacted biological
research by providing the principles to ‘knock in’ and
‘knock out’ genes (7). The observation that the induction
of site-speciﬁc double-strand chromosomal breaks
stimulates homology-directed gene repair (8,9) provided
a rationale for the development of artiﬁcial zinc ﬁnger
nucleases (ZFNs) (10–13). ZFNs consist of a modular
assembly of zinc ﬁnger domains covalently linked to the
nuclease motif of the Type IIS restriction endonuclease
FokI. The former domains confer speciﬁcity to the
double-strand DNA breaks generated by dimers of the
latter. Indeed, ZFNs can cleave predeﬁned sequences
in the genomes of higher eukaryotes and thereby increase
the frequency of HR between donor and recipient
sequences by 3–4 orders of magnitude. These ﬁndings
have greatly improved the prospects for the application
of HR-based genome editing methods in clinical and
industrial settings. For instance, eﬃcient gene targeting
at speciﬁc loci could be used to rescue genetic disease
phenotypes while avoiding insertional oncogenesis as
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treat X-linked severe combined immunodeﬁciency (14).
Although ZFNs have great potential, the clinical
application of these proteins awaits technical improve-
ments such as the reduction of oﬀ-target chromosomal
double-strand breaks and associated cytotoxicity as
well as the control of their activity in target cells (15).
An alternative HR-based gene editing strategy consists
of exploiting the recombinogenic nature of adeno-
associated virus (AAV) vector genomes (16). Several
reports have demonstrated that AAV vectors can be
tailored to introduce precise nucleotide alterations into
the human genome at frequencies approaching 1% when
very high multiplicities of infection are used (i.e. 10
5–10
6
genome copies per cell). In comparison with other
methods, the AAV vector-mediated HR process seems to
be less dependent on the extent of homology between
donor and target templates. Currently, however, with
this method, each targeted gene conversion event is
accompanied by approximately 10 random DNA
insertions (17).
Historically, single-strand and double-strand DNA
breaks have both been invoked as the initiators of
homology-directed DNA repair in HR models.
However, experimental indications that single-strand
DNA gaps or nicks may constitute, per se, triggers for
HR have only recently been obtained (18). Instrumental
to this conclusion was the deployment of mutant RAG
proteins that preferentially nick instead of cleave their
recombination signal sequences and a reporter gene
expression rescue assay based on plasmids containing
two non-functional but complementary cyan ﬂuorescent
protein gene segments (18).
Here, we investigated whether a bona ﬁde nicking endo-
nuclease could stimulate HR at a predeﬁned native human
locus, and by doing so, could be used for the targeted
chromosomal insertion of a functional transcription
unit. For this purpose, we exploited the ability of the
two largest AAV Rep proteins (i.e. Rep78 and Rep68)
to introduce a single-strand DNA break in a locus on
the long arm of human chromosome 19 designated
AAVS1. Introduction into human cells of these sequence-
and strand-speciﬁc endonucleases together with donor
templates consisting of a 4.1-kb humanized Renilla
reniformis green ﬂuorescent protein (hrGFP) transcription
unit ﬂanked by sequences homologous to AAVS1 greatly
enhanced homology-directed gene addition. These results
demonstrate that a sequence- and strand-speciﬁc endo-
nuclease can stimulate targeted insertion of new genetic
information into a predeﬁned human genomic region in
its native chromosomal context.
MATERIALS AND METHODS
DNA constructions
The AAV rep78/68 expression plasmid pGAPDH.
Rep78/68 has been described before (19). The annotated
nucleotide sequences of the expression plasmids
pGAPDH.Rep68 and pGAPDH.Rep68(Y156F) encoding
endonuclease-proﬁcient and -deﬁcient versions of Rep68,
respectively, as well as that of the targeting vector
pA1.GFP.A2 can be retrieved through GenBank acces-
sion numbers, GQ380656, GQ380657 and GQ380658,
respectively.
DNA transfections
Eighty thousand human cervical carcinoma (HeLa) cells
(American Type Culture Collection) in wells of 24-well
plates (Greiner Bio-One) were co-transfected with
pA1.GFP.A2 and pGAPDH.Rep78/68 at a molar ratio
of 2:1 or with pA1.GFP.A2 and an ‘empty plasmid’
using ExGen500 (Fermentas). The total amounts of
transfection reagent and plasmid DNA were 2.4ml and
0.4mg per well, respectively. Twenty-four hours after trans-
fection, the cells received fresh culture medium [Dulbecco’s
modiﬁed Eagle’s medium (DMEM; Invitrogen) plus 10%
fetal bovine serum (FBS; Invitrogen)]. Cultures exposed to
the ‘empty’ plasmid and to the rep78/68 expression vector
contained 69% 7.1 (n=3) and 68.4% 2.1 (n=3)
hrGFP-positive cells, respectively, as determined by
ﬂow cytometry 48h post-transfection (10000 events
measured per sample). The transfected cells as well as
non-transfected control cells were sub-cultured every 3–4
days for 4 weeks in order to allow the identiﬁcation,
through direct ﬂuorescence microscopy and ﬂow
cytometry, of stably transduced HeLa cells. Next, the
cells were sorted to establish single-cell clones. Trans-
fection experiments using constructs pGAPDH.Rep68
and pGAPDH.Rep68(Y156F) were performed as those
described above using pGAPDH.Rep78/68.
Cell sorting and clonal expansion
hrGFP-based cell sorting was carried out 4 weeks post-
transfection to permit loss of episomal pA1.GFP.A2
donor templates. Cells were collected in a 1:1 mixture
of DMEM and FBS. The sorted hrGFP-positive cells
were seeded in wells of 96-well plates (Greiner Bio-One)
at a density of 0.3 cells per well in DMEM containing 10%
FBS, 50mM a-thioglycerol (Sigma-Aldrich) and 20nM
bathocuprione disulphonate (Sigma-Aldrich) to increase
the cloning eﬃciency (20). Twenty-four randomly picked
clones derived from the HeLa cells transfected with
pA1.GFP.A2 and pGAPDH.Rep78/68 and 25 clones
selected at random from the sorted HeLa cells that
received pA1.GFP.A2 and the ‘empty vector’ were used
for further analysis.
Flow cytometry
Quantiﬁcation of hrGFP-positive cells was performed
using a BD LSR II ﬂow cytometer. Data were analyzed
with the aid of BD FACSDiva software version 5.0.1 with
non-transfected HeLa cells serving to set the background
level of the assay at zero events. At least 10000 events
were acquired per sample.
Detection of gene targeting events by Southern
blot analysis
Chromosomal DNA was puriﬁed according to a published
method (21). After overnight digestion with ApaLI
5726 Nucleic Acids Research, 2009, Vol. 37,No. 17(New England Biolabs), 10mg DNA samples were
resolved in a 0.8% agarose gel in 1  Tris–acetate–
EDTA buﬀer. Next, the DNA was transferred by capillary
action to an Amersham Hybond-XL membrane (GE
Healthcare) using a standard Southern blot technique.
The 393-bp AAVS1-speciﬁc probe was obtained by
PCR ampliﬁcation of human chromosomal DNA using
0.012U/ml Phusion High-Fidelity DNA polymerase
(Finnzymes), 200mM deoxynucleoside triphosphates
(dNTPs; Fermentas), 1  GC buﬀer (Finnzymes) plus
0.2mM of primers #633 (50-GGTCCCCAGCATGTCTT
CCTA-30) and #634 (50-CTCCCGAACCTCAGATCT
CC-30). The resulting DNA fragment was puriﬁed after
agarose gel electrophoresis with the aid of the QIAEX II
gel extraction kit (Qiagen). The 738bp hrGFP-speciﬁc
probe was obtained by digestion of plasmid
pU.CAG.hrGFP (22) with EcoRI and NotI (both from
Fermentas) followed by preparative agarose gel
electrophoresis. Both DNA probes were labeled with
(a-
32P)dATP (GE Healthcare) using the HexaLabel
DNA labeling system (Fermentas). Prior to their applica-
tion in hybridization experiments, the radiolabeled probes
were separated from unincorporated dNTPs through size-
exclusion chromatography using Sephadex-50 (GE
Healthcare) columns. The PCR ampliﬁcations were
carried out in a DNA Engine Tetrad 2 thermal cycler
(Bio-Rad).
Detection of gene targeting events by PCR
PCR ampliﬁcations were performed on chromosomal
DNA puriﬁed from hrGFP-positive cell clones derived
from cell populations initially transfected with
pA1.GFP.A2 and either the ‘empty plasmid’ or
pGAPDH.Rep78/68. Cellular DNA extracted from par-
ental non-transfected cells served as negative control.
Samples containing 100ng of genomic DNA were
subjected to PCR with the AAVS1-speciﬁc primer #649
(50-AGGCTTGCTCTGCACAACTT-30), together with
primer #651 (50-TTCCTAACCCCAACACTTGC-30)
targeting the human elongation factor 1  (EF1 ) promoter
located in pA1.GFP.A2. Fifty microliters PCR mixtures
containing 0.2mM of each primer, 200mM dNTPs, 0.6U
of Phusion High-Fidelity DNA polymerase and HF buﬀer
(Finnzymes) at a 1  ﬁnal concentration were placed in a
DNA Engine Tetrad 2 thermal cycler and a touchdown
PCR program was initiated by 1-min incubation at 988C.
This was followed by 36 cycles consisting of 20s at 988C,
30s at 728C with the temperature decreasing 0.58C per
cycle and 2min at 728C. When the PCR program reached
the lower annealing temperature of 548C, 16 additional
cycles were carried out at this annealing temperature.
The procedure was completed by 5-min incubation at
728C. To control for the integrity of the genomic DNA,
PCR ampliﬁcations with the hypoxanthine phosphoribosyl-
transferase 1 (HPRT1)-speciﬁc primers hHPRT.1 and
hHPRT.2 (23) were carried out using the conditions and
cycling parameters speciﬁed above. Semi-nested PCR
ampliﬁcations were done by using primer #649 and the
EF1  promoter-speciﬁc primer #186 (50-CTATGTGGC
CAACGCTAAG-30) on 0.004% of the DNA synthesized
with the aid of oligodeoxyribonucleotides #649 and #651.
A touchdown PCR cycling program was initiated by 45-s
incubation at 988C. This was followed by 20 cycles
consisting of 25s at 988C, 30s at 728C with the tempera-
ture decreasing 0.58C per cycle and 2min at 728C. When
the program reached the lower annealing temperature of
628C, 24 additional cycles were carried out at this
annealing temperature. The procedure was ﬁnished by
5-min incubation at 728C.
Effect of Rep68 dose on HR-mediated gene targeting
To study the eﬀect, in human cell cultures, of diﬀerent
Rep68 dosages on HR-mediated gene targeting, 8 10
4
HeLa cells were transfected essentially as speciﬁed
above. Controls consisted of mock-transfected HeLa
cells and of HeLa cells transfected with 0.2mgo f
pA1.GFP.A2 and either 0.1mg of ‘empty plasmid’ or
0.1mg of pGAPDH.Rep68(Y156F). In parallel, HeLa
cells were transfected with 0.2mg of pA1.GFP.A2 mixed
with increasing quantities of pGAPDH.Rep68 (i.e. 1, 3.3,
10, 33.3 and 100ng). A total amount of 0.3mg of recom-
binant DNA was transfected in each experimental con-
dition by adding, whenever required, extra ‘empty
plasmid’. At 3 days post-transfection live-cell light micros-
copy was performed to establish similar transfection
eﬃciencies among the diﬀerent experimental conditions.
In this analysis, an Olympus IX51 inverse ﬂuorescence
microscope equipped with a ColorView II Peltier-cooled
charge-coupled device camera was deployed. Images were
archived by using analysis software (Soft Imaging
Systems). At 4 days after transfection, genomic DNA
was extracted (21) and 1mg was incubated overnight at
378C with DpnI to selectively digest possible remaining
plasmid input. Next, the genomic DNA was analyzed by
PCR and semi-nested PCR as described above except that
for the PCR the cycling conditions of the semi-nested PCR
were used. To control for the integrity of the genomic
DNA, PCR ampliﬁcations with the HPRT1-speciﬁc
primers hHPRT.1 and hHPRT.2 (23) were carried out
using the same conditions and cycling parameters.
Molecular characterization of junctions between
exogenous and endogenous DNA
The ampliﬁcation of left (i.e. telomeric) transgene-host
DNA junctions has been described above. Their centro-
meric (i.e. right) counterparts were ampliﬁed following
essentially the same protocol except for the use of primers
#635 (50-GCACTTTGGGTGAATTGTAGG-30) and
#650 (50-GGGAGGTGTGGGAGGTTTT-30) and GC
instead of HF buﬀer. Prior to nucleotide sequencing ana-
lysis using the 3730xl DNA analyzer and BigDye
Terminator v3.1 cycle sequencing kit (both from Applied
Biosystems), PCR products representing left- and right-
hand AAVS1-transgene junctions were cloned into
plasmids pCR-blunt-II TOPO (Invitrogen) and pJet1.2
(Fermentas), respectively, according to the manufacturers’
instructions.
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Mean and SEM values were computed using GraphPad
Prism software version 4.03. Student’s t-test was used to
compare data sets. P<0.05 was considered signiﬁcant.
RESULTS
Experimental model and strategy
The AAV rep gene encodes four overlapping non-
structural proteins (dubbed Rep78, Rep68, Rep52 and
Rep40) from a single open reading frame (ORF) by a
combination of alternative promoter usage and splicing.
Biochemically, Rep78 and Rep68 are virtually indistin-
guishable (24). During AAV DNA replication, they cata-
lyze the strand- and site-speciﬁc cleavage of viral
replicative intermediates at the so-called terminal reso-
lution site (trs) to generate a free 30 hydroxyl group for
DNA chain elongation. Nicking of AAV DNA at the trs is
dependent on the binding of Rep78 and Rep68 to a nearby
Rep-binding element (RBE). A trs and an adjacent, prop-
erly spaced RBE are also present in the human genome at
19q13.3-qter (AAVS1 locus). These elements are utilized
for the Rep78/68-dependent insertion of AAV DNA at the
AAVS1 locus in human chromosome 19 (25,26).
Here, we exploited the sequence- and strand-speciﬁc
endonuclease activities of Rep78/68 to study whether
a single-strand DNA break could serve as an initiator
of HR between added foreign DNA and a predeﬁned
endogenous human locus. To serve as donor template
for HR, we generated the targeting construct pA1.
GFP.A2, which contains a human EF1  promoter-
driven hrGFP expression unit ﬂanked by DNA segments
(‘arms’) homologous to sequences framing the AAV DNA
pre-integration site on human chromosome 19 at
19q13.3-qter (Figure 1A). The presence in pA1.GFP.A2
of a recombinant hrGFP gene allowed us to trace, accur-
ately quantify and sort genetically modiﬁed cells inde-
pendently of the mechanism by which genetic
modiﬁcation of the target cells was brought about. The
latter aspect is important because it avoids the exclusive
detection of homology-dependent gene targeting events to
the detriment of non-targeted exogenous DNA insertions
as occurs in commonly used assays based on HR-mediated
rescue of reporter gene expression. Clearly, however, the
occurrence of integration events involving either truncated
reporter genes or reporter genes bearing function-
impairing mutations can be scored by neither of the two
assays.
The AAV Rep78/68 proteins stimulate homology-
directed gene targeting of an entire transcription
unit into AAVS1
HeLa cells were co-transfected with pA1.GFP.A2 and
either the AAV rep78/68 expression plasmid pGAPDH.
Rep78/68 or an ‘empty’ control vector. Stably transduced
cells present in both target cell populations were identiﬁed
following extensive subculturing by virtue of their hrGFP-
speciﬁc ﬂuorescence. Forty-four days after transfection,
the frequency of hrGFP-positive cells had stabilized in
both types of cell populations. However, the cultures
derived from the pGAPDH.Rep78/68-transfected HeLa
cells contained more stably transduced cells than those
of HeLa cells not exposed to the rep78/68 expression
plasmid (Figure 1B).
We next asked whether stable genetic modiﬁcation of
cells in each of these experimental groups was brought
about by targeted or by random DNA insertion. To this
end, hrGFP-positive cells from the two diﬀerent setups
were independently sorted and clonally expanded.
Subsequently, genomic DNA extracted from randomly
selected cell clones (n=49) was subjected to PCR analysis
using primers #649 and #651 speciﬁc for the AAVS1 locus
and the EF1  promoter, respectively (Figure 2A).
Parental, non-transfected HeLa cells served as negative
control. Homology-directed gene targeting at AAVS1
following transfection of pA1.GFP.A2 should originate
a 2652bp PCR fragment (Figure 2A). Products with a
Figure 1. Stable genetic modiﬁcation of human cells with a targeting
vector containing sequences homologous to the genomic region ﬂanking
the RBE and trs of AAVS1.( A) Schematic representation of the
experimental setup used to test the capacity of a nicking endonuclease
to induce homology-directed gene targeting at a native human locus.
The episomal donor template pA1.GFP.A2 (12.7kb) contains a 4.1-kb
transcription unit consisting of the EF1  promoter (red box), the
hrGFP ORF (green box) and the simian virus 40 polyadenylation
signal (pink box). This transcription unit is ﬂanked by sequences hom-
ologous to those framing the trs (vertical thin black line) and RBE
(cyan box) at the chromosomal acceptor site (i.e. the AAVS1 locus
on human chromosome 19 at 19q13.3-qter; thick horizontal yellow
lines). Homology arms 1 and 2 are 2063 and 4381bp in length,
respectively. Black crosses represent crossing-over events between hom-
ologous DNA segments that lead to targeted gene addition. (B) Flow
cytometric quantiﬁcation of stably transduced human cells. HeLa cells
were co-transfected with pA1.GFP.A2 and an ‘empty’ control vector
( Rep) or with pA1.GFP.A2 and the AAV serotype 2 rep78/68-
expression construct pGAPDH.Rep78/68 (+Rep). The overall fre-
quency of genetically modiﬁed cells (i.e. irrespective of whether they
were stably transduced via random or via AAVS1-targeted exogenous
DNA insertion events) was determined at 44 days post-transfection
through hrGFP-based ﬂow cytometric analysis of 100000 events per
sample. Bars represent mean SEM of three independent experiments.
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in 71% (n=24) of PCR samples corresponding to
DNA of cell clones derived from cultures exposed to
pA1.GFP.A2 and pGAPDH.Rep78/68 (Figure 2B,
upper GT panel). Conversely, consistent with the well-
established very low frequency of HR in HeLa cells
(i.e. 10
 7 to 10
 8), the PCR assay performed on DNA
of cell clones established from pA1.GFP.A2-positive
cells that did not receive the AAV rep78/68 expression
plasmid yielded non-speciﬁc ampliﬁcation products
(n=25) (Figure 2B, lower GT panel). The identity of
the PCR products corresponding to three clones whose
founder cells had been co-transfected with pA1.GFP.A2
and pGAPDH.Rep78/68 was further investigated by semi-
nested PCR using the primer pairs #649 and #186
(Figure 2A). Unambiguous detection of speciﬁc 2.3-kb
semi-nested PCR products displaying diagnostic restric-
tion patterns after digestion with ApaLI, PauI or SmaI
conﬁrmed that these DNA molecules indeed represented
AAVS1-transgene junctions (Figure 2C).
To further substantiate these results through an inde-
pendent method, we deployed Southern blot analyses of
ApaLI-digested genomic DNA extracted from randomly
selected clones originating from pA1.GFP.A2-transfected
HeLa cells that had or had not been exposed to
pGAPDH.Rep78/68. Gene conversion resulting from
HR between pA1.GFP.A2 and endogenous AAVS1
sequences should yield 9.9-kb DNA species while
undisrupted/non-targeted alleles should give rise to
7.1-kb DNA molecules (Figure 3A). Autoradiograms of
Southern blots incubated with the AAVS1-speciﬁc probe
showed the presence of 9.9-kb DNA fragments consistent
with HR-mediated transgene insertion at AAVS1
(Figure 3B, upper panel, open arrowheads). Importantly,
these DNA species occurred exclusively in chromosomal
DNA of cell clones derived from cultures transfected with
pGAPDH.Rep78/68. In genomic DNA of cell clones
isolated from cultures that received the ‘empty’ control
vector, the 7.1-kb ApaLI fragments (resulting from
unmodiﬁed AAVS1 alleles) were the only DNA species
detected (Figure 3B, upper panel, solid arrowhead).
These results are in agreement with those obtained by
PCR analysis (Figure 2). To strengthen the assertion
that the 9.9-kb molecules represent HR-dependent gene
targeting events at AAVS1, the human chromosome
19-speciﬁc probe was removed and the stripped membrane
was incubated with a transgene-speciﬁc probe. The
hybridization of the 9.9-kb DNA fragments to the new
probe indicates that they are speciﬁc and result from
Figure 2. PCR assays to identify cells genetically modiﬁed through
homology-directed gene targeting. (A) Overview of the PCR assays
carried out on genomic DNA of stably transduced HeLa cells clonally
expanded from cultures exposed (+Rep) or not exposed ( Rep) to
pGAPDH.Rep78/68. The AAVS1 locus is depicted before and after
HR with the donor template pA1.GFP.A2. HR-mediated transgene
insertion should yield 2.7-kb PCR products using primers #649 and
#651 (horizontal dark blue bar). The speciﬁcity of these amplicons
can be conﬁrmed by semi-nested PCR using primers #649 and #186
combined with restriction fragment length analyses of the resulting
2.3-kb DNA species (horizontal brown bars). The numbers above the
brown bars refer to restriction fragment sizes. Open circle, prokaryotic
origin of replication. For an explanation of the other symbols see the
legend of Figure 1. (B) PCR analysis carried out on chromosomal
DNA of parental HeLa cells (HeLa) and of clones derived from
HeLa cells co-transfected with pA1.GFP.A1 and pGAPDH.Rep78/68
(+Rep) or with pA1.GFP.A2 and ‘empty plasmid’ ( Rep). The panels
labeled GT display the results of ampliﬁcation reactions performed
with primers #649 and #651, which are speciﬁc for the AAVS1 locus
and the EF1  promoter, respectively. PCR ampliﬁcations targeting a
1.9-kb segment of the HPRT1 were carried out in parallel to ascertain
the integrity of the genomic DNA corresponding to individual HeLa
cell clones (see panels marked HPRT1). PCR mixtures containing water
instead of DNA served as a negative control (H2O). The positions and
sizes (in kilo base pairs) of speciﬁc PCR products are indicated at the
right. Marker, Gene Ruler DNA Ladder Mix molecular weight marker
(Fermentas). (C) Characterization of the 2.7-kb ampliﬁcation products
obtained with primers #649 and #651 by semi-nested PCR and restric-
tion enzyme fragment length analyses. A semi-nested PCR using
primers #649 and #186 was performed on the 2.7-kb amplicons
corresponding to clones 2, 4 and 5. The resulting 2.3-kb PCR products
were subjected to agarose gel electrophoresis after digestion with
ApaLI, PauI or SmaI. Und., undigested PCR fragments.
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lower panel, open arrowheads). Of note is also the
co-labeling by both probes of DNA species with higher
molecular weights in lanes containing genomic DNA of
cells expanded from pGAPDH.Rep78/68-transfected
cultures (Figure 3B, open arrows). Possibly, these DNA
fragments represent exogenous DNA insertion events at
AAVS1 loci that went through local Rep78/68-induced
DNA ampliﬁcation/rearrangement [see e.g. ref. (27)]
prior to or concomitant with exogenous gene addition.
These events might have occurred via a homology-
independent pathway such as that at play during locus-
speciﬁc wild-type AAV DNA integration (25–27) or
non-homologous end joining or, alternatively, through
homology-directed DNA targeting as found in the other
cells (Figure 3B, open arrowheads). Detailed molecular
analysis of the structural organization of the integrated
exogenous DNA and its ﬂanking sequences will provide
clues as to which mechanism was involved.
The observation that chromosomal DNA extracted
from clones 26, 30 and 32 not only gave rise to high-
molecular-weight ApaLI fragments (>12.7kb) recognized
by both Southern blot probes but also yielded the 2652bp
PCR species, suggests the involvement of HR at some
stage during their genetic modiﬁcation. Furthermore, in
agreement with the aforementioned lack of AAVS1
disruptions, genomic DNA of cell clones derived from
Rep78/68-negative cells gave rise to transgene-speciﬁc
fragments with diﬀerent sizes (Figure 3B, lower panel).
Importantly, none of these fragments was recognized by
the AAVS1-speciﬁc probe conﬁrming that they originate
exclusively from random chromosomal insertion of
exogenous DNA.
The Rep68 protein suffices to induce homology-directed
gene targeting at AAVS1 and its endonucleolytic
activity is fundamental to this process
The smaller Rep68 protein contains all the structural
information required for binding to and nicking at RBE
and trs sequences, respectively. Thus, we postulated that
the HR-inducing activity of Rep78/68 discovered above
would be recapitulated by expressing exclusively Rep68.
To test this hypothesis, we generated the expression plas-
mid pGAPDH.Rep68. This construct encodes Rep68
only. Moreover, to establish whether the stimulatory
eﬀect of the large AAV Rep proteins on HR-mediated
gene targeting depends on their nicking activity, expres-
sion plasmid pGAPDH.Rep68(Y156F) was made. This
construct is identical to pGAPDH.Rep68 except for
a point mutation within the rep68 ORF that confers a
nicking-defective phenotype to the encoded protein
[designated Rep68(Y156F)] due to substitution of the
tyrosine residue at amino acid position 156 by phenylalan-
ine (28,29). Both AAV rep68 expression plasmids were
independently co-transfected into HeLa cells together
with the targeting vector pA1.GFP.A2 and, as before,
cells stably transduced with pA1.GFP.A2 sequences were
identiﬁed by hrGFP-speciﬁc ﬂow cytometry following
Figure 3. Investigation of targeted versus random chromosomal insertion of exogenous DNA through restriction mapping and Southern blot
analyses. (A) Diagram of the Southern blot assay performed on ApaLI-digested chromosomal DNA extracted from randomly selected clones of
pA1.GFP.A2-transfected HeLa cells. The ApaLI restriction map of the AAVS1 locus is depicted before and after HR with the donor template
pA1.GFP.A2. Non-targeted and targeted human chromosome 19 alleles are expected to give rise to 7.1- and 9.9-kb ApaLI DNA fragments,
respectively, using the AAVS1-speciﬁc probe (orange horizontal bar). The 9.9-kb DNA species should also be speciﬁcally recognized by the
transgene-speciﬁc probe, which spans the entire hrGFP ORF (green horizontal bar). Both DNA probes are drawn in relation to their target
sequences. For an explanation of the other symbols see the legend of Figure 1. (B) Southern blots of ApaLI-digested chromosomal DNA of parental
HeLa cells (HeLa) and of clones derived from HeLa cells co-transfected with pA1.GFP.A1 and pGAPDH.Rep78/68 (+Rep) or with pA1.GFP.A2
and ‘empty plasmid’ ( Rep). The open arrowheads point at the 9.9-kb DNA fragments expected to emerge following homology-directed gene
targeting at AAVS1. The open arrows mark higher molecular weight DNA species that are also recognized by both probes indicating insertion of
exogenous DNA at AAVS1 loci that underwent local Rep78/68-induced DNA ampliﬁcation/rearrangement. The 12.7-kb ApaLI-linearized
pA1.GFP.A2 DNA (solid arrowhead in lower panel) served as an internal control for probe binding speciﬁcity and removal. The solid arrowhead
in the upper panel points at the 7.1-kb ApaLI fragments derived from unmodiﬁed AAVS1 alleles. Marker, Gene Ruler DNA Ladder Mix molecular
weight ladder (Fermentas).
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frequency of stably transduced cells was higher in cell
cultures initially exposed to pGAPDH.Rep68 than in
those transfected with pGAPDH.Rep68(Y156F). Next,
the PCR-based assay illustrated in Figure 2A was
deployed to investigate homology-directed gene targeting
at AAVS1 in cells that received either Rep68 or
Rep68(Y156F). Genomic DNA extracted from non-
transfected HeLa cells and from HeLa cell clone 25
(Figure 2B, upper two panels) served as negative and posi-
tive controls, respectively. Speciﬁc 2.7-kb PCR products
were only detected in samples of cell populations derived
from cultures initially provided with Rep68 molecules.
These data demonstrate that Rep68 alone can induce
HR-mediated gene targeting at AAVS1 and that its
nicking activity is involved in this process (Figure 4B).
The conﬁrmation that the 2.7-kb PCR products resulted
from HR-mediated gene targeting at AAVS1 was obtained
by the detection of diagnostic 2.3-kb DNA fragments
(Figure 4B) following semi-nested PCR using primers
#649 and #186 (Figure 2A). To determine the amount of
rep68 expression plasmid required to induce detectable
HR-mediated chromosomal gene targeting, we performed
a dose-response experiment in HeLa cells using as read-
out the PCR assay depicted in Figure 2A. The HeLa cells
were transfected with a constant amount of targeting
vector pA1.GFP.A2 mixed with increasing quantities of
pGAPDH.Rep68 ranging from 1 to 100ng. Light micros-
copy analyzes revealed that transfection eﬃciencies were
similar for each experimental condition (Figure 5A). The
PCR assay detected AAV Rep68-dependent HR events
at AAVS1 in cells exposed to 33.3 and 100ng of
pGAPDH.Rep68 (Figure 5B). Moreover, these events
could not be detected in cells receiving 100ng of
pGAPDH.Rep68(Y156F) conﬁrming that Rep68-
dependent nicking is necessary for the observed stimula-
tion of homology-directed gene targeting at chromosomal
DNA in human cells (Figure 5B).
Chromosomal junctions between endogenous and
exogenous DNA generated by AAV Rep78/68-mediated
HR are accurate
Finally, we asked whether the junctions between AAVS1
and foreign DNA in cells stably transduced through AAV
Rep-induced HR were precise at the nucleotide level. To
this end, we performed PCR ampliﬁcations on genomic
DNA from cell clones 4, 7 and 9 with the aid of primer
sets #649 plus #651 and #635 plus #650 to amplify,
respectively, left (i.e. telomeric) and right (i.e. centromeric)
junctions between endogenous and exogenous DNA
(Figure 6A). The resulting diagnostic 2.7- and 5.4-kb
PCR fragments were subsequently cloned and the cloning
products were used to molecularly characterize all 12
AAVS1-foreign DNA junctions. Nucleotide sequence
Figure 4. Testing the capacity of endonuclease-proﬁcient Rep68 and
endonuclease-deﬁcient Rep68(Y156F) proteins to stimulate homology-
directed gene targeting at AAVS1.( A) Quantiﬁcation by ﬂow cytometry
of stably transduced HeLa cells following co-transfection with
pA1.GFP.A2 and pGAPDH.Rep68(Y156F) or with pA1.GFP.A2 and
pGAPDH.Rep68 (Rep68). The frequency of genetically modiﬁed cells
was determined at 27 days post-transfection through hrGFP-based ﬂow
cytometric analysis of 10000 events per sample. Bars represent
mean SEM of three independent experiments. (B) Agarose gel electro-
phoresis of PCR products resulting from ampliﬁcations carried out on
chromosomal DNA from HeLa cell clone 25 (Figure 2B, upper two
panels) (lane 1), parental HeLa cells (lane 2) and HeLa cell populations
1 month after co-transfection with pA1.GFP.A2 and pGAPDH.Rep68
(lane 3) or with pA1.GFP.A2 and pGAPDH.Rep68(Y156F) (lane 4).
Lanes M, Gene Ruler DNA Ladder Mix molecular weight marker.
Upper panel, internal control PCR products resulting from
ampliﬁcations performed with the human HPRT1-speciﬁc primers
hHPRT.1 (#49) and hHPRT.2 (#50). Middle panel, PCR species
obtained after ampliﬁcations carried out with oligodeoxyribonucleotides
#649 and #651 (Figure 2A, upper panel). Lower panel, semi-nested PCR
products resulting from PCR reactions using primers #649 and #186
(Figure 2A, upper panel) on 0.004% of the DNA synthesized with the
aid of oligodeoxyribonucleotides #649 and #651. The positions and sizes
(in kilo base pairs) of the various amplicons are indicated by solid
arrows.
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and/or microrearrangements (e.g. small deletions and/or
insertions) at both sides of the two homology arms
(Figure 6B). These results together with those of the
PCR (Figure 2) and Southern blot (Figure 3) experiments
ﬁrmly establish the capacity of an enzyme with sequence-
and strand-speciﬁc endonuclease activity to trigger
homology-directed insertion of a functional expression
unit at a native locus in the human genome.
DISCUSSION
We found that a nicking endonuclease can stimulate by
several orders of magnitude homology-directed insertion
of at least 4.1kb of foreign genetic information into
a native human chromosomal locus. Stable gain-of-
function through homology-directed DNA targeting was
demonstrated by combining ﬂow cytometric, PCR,
Southern blot and DNA sequence analyses. Consistent
with the exceedingly low level of spontaneous HR in mam-
malian cells in general and in HeLa cells in particular, no
targeted gene addition events were detected in
pA1.GFP.A2-transfected HeLa cells in the absence of
the AAV Rep78/68 proteins. Importantly, the HR stimu-
latory eﬀect could be attributed to the single-strand
endonucleolytic activity of these proteins as demonstrated
in experiments deploying Rep68 and its nicking-defective
mutant Rep68(Y156F). Thus, on the basis of these proof-
of-principle experiments, we propose that protein
engineering strategies for gene targeting purposes are
expanded to include not only enzymes or enzyme
complexes, which induce double-strand DNA breaks,
but also those that simply produce single-strand DNA
lesions. Finally, our results on harnessing the cellular
HR pathway using the Rep78/68 endonucleases increases
the range of AAV-based approaches to bring about stable
genetic modiﬁcation of human cells (16,17,30,31). A pos-
sible advantage of exploiting the cellular HR machinery
during Rep78/68-mediated targeted gene addition is the
insertion of exogenous DNA devoid of AAV cis-acting
elements. This feature should prevent the integrated
DNA from becoming a target for Rep78/68-induced
rearrangements. In addition, if carefully designed, a
targeting construct containing within its arms of hom-
ology PPP1R12C (also known as MBS85) sequences
should, in principle, lead to the reconstitution of this
Figure 5. Rep68 dose dependency of HR-mediated gene targeting at AAVS1.( A) Phase-contrast microscopy (upper panel) and hrGFP direct
ﬂuorescence microscopy (lower panel) of HeLa cells that were mock-transfected (mock) and of HeLa cells that were transfected with targeting
vector pA1.GFP.A2 mixed with ‘empty plasmid’ ( Rep) or mixed with plasmid pGAPDH.Rep68(Y156F) encoding the endonuclease-deﬁcient
version of Rep68 Y156F. In parallel, phase-contrast microscopy (upper panel) and hrGFP direct ﬂuorescence microscopy (lower panel) was carried
out on HeLa cells transfected with pA1.GFP.A2 together with increasing amounts of rep68 expression construct pGAPDH.Rep68 (i.e. 1, 3.3, 10, 33.3
and 100ng). The total amount of transfected recombinant DNA was kept constant by adding, whenever required, extra ‘empty plasmid’.
Micrographs were acquired at 72-h post-transfection. Numerals below the various columns correspond to the deployed amounts (in nanograms)
of the rep68 expression plasmids and of the pA1.GFP.A2 targeting DNA. Original magniﬁcation: 100 .( B) Agarose gel electrophoresis of PCR
products resulting from ampliﬁcations performed on genomic DNA samples with the aid of primers #649 and #651 plus primers #649 and #186
(upper panel), as diagrammed in Figure 2A. Genomic DNA was isolated at 4 days post-transfection from mock-transfected HeLa cells (mock), from
HeLa cells co-transfected with pA1.GFP.A2 and ‘empty plasmid’ ( Rep), from HeLa cells co-transfected with pA1.GFP.A2 and
pGAPDH.Rep68(Y156F) (Y156F), and from HeLa cells transfected with pA1.GFP.A2 mixed with increasing amounts of pGAPDH.Rep68 (i.e.
1, 3.3, 10, 33.3 and 100ng) (upper panel). The negative ( ) and positive (+) controls were obtained using nuclease-free water and genomic DNA
isolated from HeLa cell clone 25 (Figure 2B, upper two panels) as starting material. Lanes M, Gene Ruler DNA Ladder Mix molecular weight
marker. Agarose gel electrophoresis of PCR species resulting from ampliﬁcations performed with the aid of the human HPRT1-speciﬁc primers
hHPRT.1 (#49) and hHPRT.2 (#50) (lower panel). These reactions were carried out in parallel and served as an internal control to monitor
chromosomal DNA integrity. The positions and sizes (in kilo base pairs) of the amplicons are indicated by solid arrows.
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(see below).
It is possible that Rep78/68-induced HR is caused by
single-strand breaks that evolve into larger and thus more
recombinogenic single-strand gaps. Recent experiments in
the recombination-prone chicken lymphoma cell line
DT40 suggest, at least in the case of immunoglobulin
V gene conversion, that such intermediates can directly
trigger HR (32). As our experiments were performed
with highly proliferating cell populations, it is also pos-
sible that Rep78/68 promotes gene targeting in a chromo-
somal context via host cell DNA replication fork stalling
at single-strand DNA breaks or gaps. Various studies
performed in prokaryotic and yeast systems have
indicated that protein-DNA barriers such as stalled
replisomes can be bypassed by HR-dependent processes
(33). Interestingly, in Saccharomyces cerevisiae, intra-
chromosomal recombination between direct repeats
containing in the intervening sequence a site-speciﬁc
nicking endonuclease gene II protein (gIIp) recognition
site, was not only dependent on gIIp expression (34,35)
but also on cell cycle progression (35). Of note, Rep78/
68 and gIIp share several key features including the ability
to cleave double-strand replicative DNA intermediates of
their cognate viruses in a sequence- and strand-speciﬁc
manner and the presence of evolutionarily conserved
motifs belonging to a superfamily of rolling circle replica-
tion initiator proteins (36).
Very recently, Smith et al. (37) used a site-directed
mutagenesis approach to convert the homing endonucle-
ase I-AniI into an enzyme (designated I-AniI K227M)
that preferentially nicks instead of cleaves its cognate
target site. Using GFP expression rescue assays they
measured gene repair frequencies in 293T cells induced
by I-AniI K227M. Because in vitro experiments showed
that I-AniI K227M also generates double-strand breaks
in a dose-dependent manner (37) and as it is very diﬃcult
to control the intranuclear concentration of an enzyme
following plasmid-driven constitutive overexpression, the
possibility remains that double-strand DNA break forma-
tion contributed to GFP repair. Of note, contrary to cur-
rent nick-inducing forms of RAG (18) and homing
endonucleases (37,38), AAV Rep78/68 proteins strictly
catalyzes the introduction of nicks in double-strand
DNA molecules (39). This feature might be useful in
studies into the mechanism(s) of DNA repair and recom-
bination initiated by single-strand DNA breaks.
Upon nicking at the trs of AAVS1, Rep78/68 initiates
local DNA rearrangements (26,27) that can lead to
duplications of chromosomal DNA sequences (40). It
has been postulated that this is caused by DNA polymer-
ization initiating at the free 30 hydroxyl group of the
nicked DNA strand. This process is thought to reconsti-
tute the downstream RBE that can subsequently serve
as de novo target for Rep78/68-mediated nicking
(e.g. 40,41). This process may explain the presence of
rearranged AAVS1 loci in at least some of the HeLa
cell clones that underwent targeted DNA insertion
(Figure 3B). Consistent with this model, a previous
study has shown that transient expression of rep68 can
lead to canonical Rep78/68-mediated targeted DNA
integration apparently in the absence of AAVS1
rearrangements (42). Random exogenous DNA insertions
in cells that underwent Rep78/68-dependent AAVS1
Figure 6. Nucleotide sequence analysis of centromeric and telomeric junctions between endogenous and exogenous DNA corresponding to three
independent Rep78/68-induced HR events. (A) Diagrammatic representation of the hrGFP transcription unit (red, green and pink boxes) inserted at
19q13.3-qter (thick horizontal yellow lines) following homology-directed gene targeting using as donor template pA1.GFP.A2 DNA. Primers used to
amplify the left- and right-hand junctions (dark and light blue half arrows, respectively) are drawn in relation to their recognition sequences. The 2.7-
and 5.4-kb PCR products speciﬁc for the telomeric and centromeric junctions are indicated by dark and light blue bars, respectively. (B) Primary
nucleotide sequence data corresponding to transition regions between the homology arms of pA1.GFP.A2 and outward host chromosomal DNA and
between the homology arms of pA1.GFP.A2 and inward transgene DNA.
Nucleic Acids Research, 2009,Vol.37, No. 17 5733disruption with or without targeted DNA insertion
could also be identiﬁed (Figure 3B, clones 26 and 16,
respectively).
The eﬀects of Rep78/68 on target cells, including
AAVS1 rearrangements, warrants further discussion in
light of the potential utility of AAV Rep endonucleases
for the targeted genetic modiﬁcation of human cells either
through the canonical pathway (30,31,40,41) or through
the HR pathway reported herein. Critically, the AAVS1
locus is located in a gene-rich region and overlaps with the
MBS85 gene (43). A very recent study indicates that
Rep78/68 induces partial duplication of MBS85 that,
intriguingly, preserves normal MBS85 transcript levels.
These authors failed to detect functional consequences
to host cells following Rep78/68-dependent wild-type
and recombinant AAV DNA integration (40). However,
it will be important to analyze larger numbers of cells from
diﬀerent cell types undergoing Rep78/68-induced AAVS1
disruptions and scrutinize in detail the consequences of
monoallelic and, possibly, biallelic MBS85 knock-out.
Moreover, studies on the eﬀects of Rep78/68 on global
karyotypic stability like those carried out for cells exposed
to the bacteriophage P1 Cre recombinase (44) or the
Streptomyces lividans fC31 integrase (45), will need to
be performed. In addition, it is known that AAV Rep78/
68 can induce cell cycle arrest and that constitutive
high-level synthesis of these proteins trigger, especially in
non-transformed cells, cytotoxicity and apoptosis (46).
Finally, although an RBE and a properly spaced trs
occur at AAVS1, the Rep78/68 DNA-binding consensus
is, to some extent, degenerate. As a consequence, Rep78/
68 can bind to other chromosomal sites as well (47) and,
possibly, interfere with the transcriptional activity of local
genes.
Given the above, it will be imperative to limit the dur-
ation of Rep78/68 activity in target cells so that the
aforementioned unwanted side eﬀects are minimized.
Ongoing work in our laboratory is focusing on generating
ligand-responsive Rep68 variants whose activity is
dependent on the clinically applicable synthetic small-
molecule drug 4-hydroxytamoxifen (4-OHT). Preliminary
results deploying functional assays indicate that a new
fusion protein between Rep68 and 4-OHT-responsive
estrogen receptor domains retains drug-dependent bio-
logical activity in human cells.
More generically, but still from an applied research
point of view, using natural and/or engineered site-speciﬁc
nicking endonucleases may have advantages over enzymes
or enzyme complexes that directly induce double-strand
DNA cleavage especially if: (i) the complexity of enhanced
gene targeting procedures can be reduced (e.g. the
coordinated action of two diﬀerent ZFNs is normally
required to generate a speciﬁc double-strand DNA
break) and (ii) making site-speciﬁc nicks will comprise a
milder process by which to accomplish enhanced gene
targeting (e.g. double-strand chromosomal breaks can be
repaired by error-prone non-homologous end-joining
or induce chromosomal translocations). In this regard,
the very recently reported engineering of nick-inducing
forms of the FokI restriction endonuclease constitutes
an interesting development (48). However, ultimately,
the merit of enzymes that generate single- instead of
double-strand chromosomal DNA breaks will depend, to
a large extent, on whether the former can per se stimulate
HR, i.e. without replication fork-dependent double-strand
chromosome break formation (18,32).
Future research aiming at deﬁning optimal nick-
inducing enzyme levels as well as transgene size
constraints for single-strand DNA break-induced HR
will proﬁt from adopting naked DNA transfection-
independent methods to eﬃciently introduce donor
templates and endonuclease-encoding genes into both
dividing and quiescent cells. Indeed, viral gene delivery
vehicles, and in particular high-capacity adenovirus
vectors, may constitute a suitable platform to examine
the impact of transgene length and dose, extent of hom-
ology and cell cycle status on nicking endonuclease-
stimulated genome editing. This relates to the fact that
these adenovirus vectors can accommodate up to 37kb
of foreign DNA and allow for highly eﬃcient cell cycle-
independent gene transfer (49,50).
In conclusion, in this study we demonstrate for the ﬁrst
time that homology-directed gene targeting at an
endogenous human locus can be triggered by a bona ﬁde
nicking enzyme and expand the number of strategies that
make use of AAV elements to bring about long-term
transgene expression in these cells. Finally, our ﬁndings
provide a rationale to devise new approaches for targeted
editing of the genomes of higher eukaryotes.
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